BNP Paribas Financial Markets Acquires 123,836 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

BNP Paribas Financial Markets raised its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 120.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 226,338 shares of the real estate investment trust's stock after purchasing an additional 123,836 shares during the quarter. BNP Paribas Financial Markets owned approximately 0.08% of Omega Healthcare Investors worth $9,212,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. FMR LLC boosted its stake in Omega Healthcare Investors by 9.9% in the 3rd quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust's stock valued at $171,625,000 after purchasing an additional 380,626 shares during the period. Daiwa Securities Group Inc. grew its stake in shares of Omega Healthcare Investors by 317.7% in the third quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust's stock valued at $160,739,000 after acquiring an additional 3,003,845 shares in the last quarter. Charles Schwab Investment Management Inc. raised its stake in Omega Healthcare Investors by 6.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 3,830,302 shares of the real estate investment trust's stock worth $155,893,000 after purchasing an additional 240,006 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of Omega Healthcare Investors by 7.9% in the second quarter. Dimensional Fund Advisors LP now owns 3,732,390 shares of the real estate investment trust's stock valued at $127,831,000 after buying an additional 272,299 shares in the last quarter. Finally, Bank of New York Mellon Corp boosted its stake in shares of Omega Healthcare Investors by 4.6% in the second quarter. Bank of New York Mellon Corp now owns 3,240,025 shares of the real estate investment trust's stock valued at $110,971,000 after buying an additional 143,521 shares during the period. 65.25% of the stock is owned by institutional investors.

Insider Buying and Selling at Omega Healthcare Investors

In related news, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares of the company's stock, valued at approximately $4,025,000. This trade represents a 36.19 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now owns 183,076 shares in the company, valued at $7,357,824.44. The trade was a 10.96 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of research firms have recently weighed in on OHI. Berenberg Bank started coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They set a "buy" rating and a $45.00 target price for the company. BNP Paribas upgraded shares of Omega Healthcare Investors from a "neutral" rating to an "outperform" rating and set a $49.00 price objective on the stock in a research note on Thursday, October 31st. Royal Bank of Canada boosted their target price on shares of Omega Healthcare Investors from $39.00 to $43.00 and gave the company a "sector perform" rating in a research report on Monday, November 11th. Truist Financial upped their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "hold" rating in a report on Wednesday, September 4th. Finally, Scotiabank lifted their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "sector perform" rating in a research note on Monday, August 26th. Seven research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $40.00.

Omega Healthcare Investors Trading Down 0.8 %

Shares of Omega Healthcare Investors stock traded down $0.30 on Tuesday, reaching $39.51. 927,679 shares of the company's stock were exchanged, compared to its average volume of 1,682,925. The firm's 50-day moving average is $40.59 and its two-hundred day moving average is $37.46. The company has a market capitalization of $10.67 billion, a P/E ratio of 29.27, a price-to-earnings-growth ratio of 1.26 and a beta of 0.98. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48. Omega Healthcare Investors, Inc. has a 52 week low of $27.53 and a 52 week high of $44.42.

Omega Healthcare Investors Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were given a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 6.78%. The ex-dividend date of this dividend was Monday, November 4th. Omega Healthcare Investors's payout ratio is currently 197.06%.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.